The UAE Retail Pharmacy Market is projected to grow from $5.193 Bn in 2022 to $9.541 Bn by 2030, registering a CAGR of 7.9% during the forecast period of 2022-2030. The market is expected to continue growing at a steady pace in the coming years, with an increasing number of retail pharmacy chains and independent pharmacies opening in the country. Lloyds Pharmacy is a leading retail pharmacy chain in the UAE, with over 70 branches across the country.
The UAE Retail Pharmacy Market is projected to grow from $5.193 Bn in 2022 to $9.541 Bn by 2030, registering a CAGR of 7.9% during the forecast period of 2022-30.
The pharmaceutical market in the United Arab Emirates (UAE) is expected to experience significant growth in the coming years, driven by factors such as an ageing population, increasing prevalence of chronic diseases, and rising healthcare expenditure. The market is segmented into prescription drugs and over-the-counter (OTC) drugs, with the prescription drugs segment accounting for a larger share of the market. The market is also segmented by therapeutic area, with cardiovascular drugs and diabetes drugs being the largest segments.
The government is actively working to improve the healthcare infrastructure in the UAE and increase healthcare expenditure, which is expected to drive the growth of the pharmaceutical market. Additionally, the presence of a large number of international and local pharmaceutical companies in the UAE, along with the availability of advanced medical technologies, is also expected to drive market growth. However, the market may face some challenges such as price controls, regulatory changes, and reimbursement issues.
The retail pharmacy market in the United Arab Emirates (UAE) is a rapidly growing industry, driven by factors such as an increasing population, rising disposable incomes, and a growing focus on preventative healthcare. The market is expected to continue growing at a steady pace in the coming years, with an increasing number of retail pharmacy chains and independent pharmacies opening in the country. The market is highly competitive, with a number of major international and regional players operating in the market. Additionally, the UAE government has implemented several measures to support the growth of the retail pharmacy market, such as implementing regulations to ensure the quality and safety of pharmaceutical products.
Market Drivers
The key drivers of the UAE retail pharmacy market include an increasing population, a growing number of tourists, and a rise in chronic diseases. Additionally, the government's efforts to improve healthcare infrastructure and increase access to healthcare services also contribute to the growth of the retail pharmacy market. An increasing focus on preventive healthcare and the availability of a wide range of over-the-counter medications also drive the market.
Market Restraints
The key restraints of the UAE retail pharmacy market include strict regulations and licensing requirements, intense competition among players, and the high cost of pharmaceutical products. Additionally, the presence of a large number of unlicensed pharmacies and the sale of counterfeit drugs also pose a significant challenge to the market. The limited insurance coverage for prescription drugs and the lack of reimbursement for certain medications also act as a restraint on the market. Finally, the limited availability of certain drugs, particularly those that are not commercially viable, can also limit the growth of the retail pharmacy market in the UAE.
Key Players
Some key players in the UAE retail pharmacy market include:
These are some of the major players operating in the UAE retail pharmacy market, however, there are other local and international players also present in the market.
The UAE retail pharmacy market is heavily regulated by the Ministry of Health and Prevention (MOHAP), as well as other government bodies such as the Dubai Health Authority (DHA) and the Abu Dhabi Department of Health (DoH).
All pharmacies operating in the UAE must be licensed by the MOHAP, and all medications sold must be approved by the Ministry. Additionally, all pharmacists working in the UAE must be licensed by the MOHAP and the Emirates Medical Association.
The government also monitors the prices of drugs and regulates the import, export, and distribution of drugs. The government also encourages the use of generic drugs as an alternative to expensive branded drugs.
The government also implemented a system of insurance coverage for prescription drugs, which helps in increasing the accessibility of drugs for people who are not able to afford them.
The UAE has also implemented strict regulations to curb the sale of counterfeit drugs, and the government actively works to prevent the influx of fake drugs into the market.
Overall, the regulatory landscape in the UAE is designed to ensure the safety and efficacy of drugs and the quality of pharmacy services and to increase the accessibility of healthcare for the population.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
Pharmacy Product
It mainly includes Pharmaceutical products and it provides information for medical treatments.
Pharmacy Type
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?